Quiz

Oncology

Prostate Cancer CME Series: Primary Care Clinical Case Scenarios

Learning Objectives
1. Recommend interventions and a treatment plan based on history, risk factors, and staging in the castration-sensitive prostate cancer (CSPC) setting
2. Develop assessment and monitoring skills in patients in the early stages of prostate cancer

0.25 Credit CME

Stanford Medicine

Activity Information and Disclosures

Published Online: May 16, 2023 Interactive

Module Take Quiz

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine.

Apply your knowledge and practice skills by examining five clinical case scenarios. This interactive learning module targets primary care clinicians who manage prostate cancer patients across the continuum of care. Each clinical case scenario allows you to work through history taking, investigations, differential diagnosis, and management. Using an interactive electronic health record (EHR) format, learners will explore early detection and intervention strategies for prostate cancer.

Take Quiz

Activity Information

All Rights Reserved. The content of this activity is protected by U.S. and International copyright laws. Reproduction and distribution of its content without written permission of its creator(s) is prohibited.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Financial Support Disclosure Statement: Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Ali R Khaki, MD

Clinical Assistant Professor

Stanford Health Care (SHC)

Course Director, Faculty

Stocks or stock options, excluding diversified mutual funds-Merck and Company, Inc. (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Sanofi-Aventis (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Doximity (Relationship has ended).

Sumit Anil Shah, MD

Stanford

Course Director, Faculty

Advisor-Natera|Grant or research support-Genentech, Inc.

Ruth Adewuya, MD, CHCP

Managing Director, Center for Continuing Medical Education

Stanford University School of Medicine

Planner

Nothing to disclose

Marilyn Mejia, BA

Education Design Coordinator

Stanford University

Planner

Nothing to disclose

Commercial Support Disclosure Statement: This CME activity is supported by an educational grant from Astellas Pharma Global Development, Inc. and its collaborative partner, Pfizer, Inc.

References:

American Cancer Society. American Cancer Society Recommendations for Prostate Cancer Early Detection. April 23 , 2021. Accessed July 19, 2022. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html

Urology Care Foundation. Benign Prostatic Hyperplasia (BPH). Sept 2021. Accessed July 19, 2022. https://www.urologyhealth.org/urology-a-z/b/benign-prostatic-hyperplasia-(bph)

Egerdie B, Saad F. Bone health in the prostate cancer patient receiving androgen deprivation therapy: a review of present and future management options. Can Urol Assoc J. 2010;4(2):129–135. doi:10.5489/cuaj.811 Google Scholar

Kotwal AA, Mohile SG, Dale W. Remaining Life Expectancy Measurement and PSA Screening of Older Men. J Geriatr Oncol. 2012;3(3):196–204. doi:10.1016/j.jgo.2012.02.003 Google Scholar

Lerner LB, McVary KT, Barry MJ, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management [published correction appears in J Urol. 2021 Nov;206(5):1339]. J Urol. 2021;206(4):806–817. Google Scholar

Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU Guideline. J Urol. 2020;204(4):778–786. doi:10.1097/JU.0000000000001297 Google Scholar

Park HJ, Won JE, Sorsaburu S, Rivera PD, Lee SW. Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil. World J Mens Health. 2013;31(3):193–207. doi:10.5534/wjmh.2013.31.3.193 Google Scholar

Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
Stanford Medicine designates this Enduring Material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Prostate Cancer CME Series: Primary Care Clinical Case Scenarios

Please finish the activity before taking the quiz.

AMA Membership provides:

Sign in to access

Sign in to customize your interests

Name Your Search

Sign in to save your search

Lookup An Activity

My Saved Searches

My Saved Courses

Purchase access